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Abstract 
Cultures of cosmomycin D-producing Streptomyces olindensis ICB20 that were 
propagated for many generations underwent mutations that resulted in production of a 
range of related anthracyclines by the bacteria. The anthracyclines that retained the two 
trisaccharide chains of the parent compound were separated by HPLC. Exact mass 
determination of these compounds revealed that they differed from cosmomycin D 
(CosD) in that they contained one to three fewer oxygen atoms (loss of hydroxyl groups). 
Some of the anthracyclines that were separated by HPLC had the same mass. The 
location from which the hydroxyl groups had been lost relative to CosD (on the aglycone 
and/or on the sugar residues) was probed by collisionally-activated dissociation using an 
electrospray ionisation linear quadrupole ion trap mass spectrometer. The presence of 
anthracyclines with the same mass, but different structure was confirmed using an 
electrospray ionisation travelling wave ion mobility mass spectrometer. 
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Introduction 
Anthracyclines are natural products produced by Streptomyces sp. bacteria of the 
actinomycetes order. They consist of an anthraquinone ring system (the aglycone) with 
various levels of glycosylation at C7 and C10 (see Figure 1 for numbering of the ring 
system). The first anthracyclines, daunorubicin (daunomycin, Dn) and doxorubicin 
(adriamycin, Dx), were isolated from Streptomyces peucetius in the 1960s.1 These 
anthracyclines contain one daunosamine sugar moiety (Figure 1) and have been used in 
the clinic for around thirty years in chemotherapy regimens against breast cancer, 
childhood solid tumours, soft tissue carcinomas, aggressive lymphomas (Dx) and acute 
lymphoblastic or myeloblastic leukaemias (Dn).1 The anticancer activities of these 
compounds are thought to be the result of their ability to bind DNA. The aglycone moiety 
intercalates between base pairs and the sugar(s) are involved in non-covalent interactions 
along the minor groove.2,3 This interaction results in the stabilization of a normally 
transient topoisomerase II-DNA adduct, and is proposed to interfere with DNA in the 
cancer cells.4 Both the substituents on the anthracycline ring system and the nature of the 
sugars affect the DNA binding affinity, the DNA sequence selectivity and the efficacy 
against different tumour cells.1,4,5 Removal of the sugars results in loss of activity. 
 Several strategies have been pursued to develop anthracyclines with a spectrum of 
activity against different tumours. These include screening of natural products produced 
by different species of Streptomyces,6 synthesis or partial synthesis of new 
anthracyclines,7 and genetic manipulation of Streptomyces sp.8 The anthracyclines most 
commonly used in the clinic, daunorubicin and doxorubicin, contain only one sugar. 
Cosmomycin D (CosD) was first isolated from Streptomyces cosmosus over twenty years 
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ago.6 This anthracycline has two trisaccharide chains, each consisting of a rhodinose 
(Rho) residue linked directly to the aglycone, 2-deoxy-L-fucose (deFuc) as the middle 
sugar and rhodosamine (RhN) at the terminus of each chain. This structure is less 
common among anthracyclines, although aclarubicin, which is also used in the clinic1 has 
one trisaccharide chain (Figure 1). 
 In early work, CosD was shown to induce differentiation in Friend (mouse) 
leukemia cells under conditions where Dn and Dx had no activity,9 suggesting that CosD 
was involved in a different set of intermolecular interactions and might be a compound 
that would have different activity in the clinic. Recently, we isolated and characterised 
CosD from Streptomyces olindensis ICB2010 and reported a detailed study of its DNA-
binding properties.11 CosD was separated by HPLC as the major component of methanol 
extracts of the bacterial cultures. When the S. olindensis ICB20 cultures had been 
propagated for many generations, difficulties arose in separation of the CosD by HPLC. 
There were many peaks in the HPLC chromatogram. Genetic instability in Streptomyces 
is well-documented,12 and it is these observations that encourage strategies of screening 
these bacterial cultures for anthracyclines with different clinical properties and genetic 
engineering to produce novel anthracyclines. 
 In the current work, a method is presented for separation of anthracyclines 
containing two trisaccharide chains from the mutants arising from S. olindensis ICB20. 
These were related to CosD, but had "lost" one to three hydroxyl groups from the 
molecule as judged by exact mass measurements using an electrospray ionisation 
quadrupole time-of-flight mass spectrometer. The position from which the hydroxyl 
group had been lost (either from the aglycone or a sugar residue) was determined by 
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collisionally-activated dissociation (up to MS5) using an electrospray ionisation linear 
quadrupole ion trap instrument. These experiments showed that some of the 
anthracyclines had the same mass, but a hydroxyl group was present on the aglycone 
rather than on the sugar (or vice versa), or was present on different sugar residues. These 
results were confirmed by ion mobility mass spectrometry. The ability of the "travelling 
wave" (Triwave™) ion mobility instrument to separate these structural isomers is 
discussed. 
Experimental 
All reagents used were of the highest grade commercially available and MilliQ™ water 
was used in all experiments. 
Separation of anthracycline fractions 
Liquid cultures of (mutant) Streptomyces olindensis ICB20 were grown as 
previously described.10 Methanol extracts of the culture supernatants contained a range of 
anthracyclines. The enhanced water solubility of those containing two trisaccharide 
chains over those containing fewer sugar residues was exploited by dissolving the crude 
extract in water, sonicating for 5 min and centrifuging in an Eppendorf microfuge 
(10,000 rpm, 4 C, 15 min). The supernatant was frozen for 60 hours, thawed slowly to 
room temperature, and centrifuged as before. The freeze-dried supernatant was dissolved 
in water (50 mg/mL) and filtered using a 0.45 m nylon syringe filter. The filtrate was 
extracted two times with ethyl acetate, and the aqueous phase was freeze-dried using a 
Savant SpeedVac. The sample was dissolved in an aqueous solution of 100 mM 
ammonium acetate and separated by HPLC using a Jupiter C4 column (Phenomenex, 10 
x 250 mm, 5 m, 300 Å) equilibrated at 3 mL/min with 100 mM ammonium acetate, pH 
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7.5, and eluted using a 0-65% acetonitrile gradient over 65 min. Fractions eluting from 
the column were analysed by measuring the absorbance at 254 nm. Cosmomycin D 
eluted at 35.2 min and was obtained as a red-purple powder after freeze-drying. Ten other 
fractions ranging in colour from brown-yellow to red-purple with elution times from 35 
to 43 min were collected for further analysis. 
Electrospray ionization mass spectrometry and exact mass of anthracyclines 
The contents of fractions from the HPLC column (above) were analysed by positive ion 
electrospray ionization mass spectrometry (ESI-MS) using a Waters Quattro Micro ESI 
mass spectrometer equipped with a Z-spray ionization source and a quadrupole mass 
analyzer with a m/z range of 4,000. Samples were injected to the mass spectrometer using 
the instrument syringe pump at a flow rate of 20 L/min. All spectra were acquired using 
an RF lens energy of 1.6 V and the cone and capillary voltages were 20 V and 3.0 kV, 
respectively. The source temperature was 80 °C and the desolvation gas flow rate was 
250 L/hr at a temperature of 80 °C. Spectra were acquired in positive ion mode over the 
range m/z 300-2000 and typically 30 scans were summed to obtained a representative 
spectrum. 
 The exact masses of anthracyclines in the fractions were determined using a 
Waters Synapt HDMS ESI mass spectrometer equipped with a lockspray attachment 
using CsI as the standard, a Z-spray ionization source and a quadrupole mass analyzer 
with a m/z range of 4,000. Samples were prepared by dissolving the compounds in a 100 
mM solution of ammonium acetate, pH 7.5, with 10 % methanol (to assist desolvation) at 
a concentration of ~10 M, then injected to the mass spectrometer using a Harvard 
Model 22 syringe pump (Natick, MA, USA) at a flow rate of 10 L/min. All spectra were 
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acquired using a MCP potential of 1800 V, capillary voltage of 2.5 kV and the sampling 
and extraction cone voltages were 80 V and 4 V, respectively. The source temperature 
was 80 °C and the desolvation gas flow rate was 400 L/hr at a temperature of 200 °C. 
Spectra were acquired in positive ion mode over the range m/z 400-2000 and typically 40 
acquisitions were summed and the corrected mass was obtained by adjusting the values to 
the CsI reference ion at m/z 1172.1450 Da. The elemental composition was determined 
by using the MassLynx elemental composition calculator. The instrument was calibrated 
using a CsI solution (1 mg/mL) over the same m/z range.  
Collisionally-activated dissociation of anthracyclines  
Fragmentation of anthracyclines in each HPLC fraction was performed using a 
ThermoFisher LTQ linear quadrupole ion trap mass spectrometer equipped with an ESI 
source. Anthracyclines (20 M) were injected into the instrument at a flow rate of 5 
L/min. Positive ion ESI mass psectra were acquired using a source voltage, capillary 
voltage and temperature of 3.71 kV, 60 V and 49 °C, respectively. For all MSn (n = 1-5) 
experiments, the isolation width was 2-3 Th, CAD fragmentations were induced using a 
collision energy of 20-40 V, and the typical activation time was 30 ms. Spectra were 
acquired over the range m/z 350-1300 and 100 scans were summed to obtain a 
representative spectrum. 
Ion mobility ESI mass spectrometry of anthracyclines 
The ion mobilities of anthracyclines from HPLC that had the same exact mass were 
analysed using the Waters Synapt HDMS ESI mass spectrometer (see above). All 
samples were prepared in 100 mM ammonium acetate, pH 7.5, at a concentration of ~5 
M, and injected to the mass spectrometer using the instrument syringe pump at a flow 
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rate of 5 L/min. All spectra were acquired using a MCP potential of 1800 V, capillary 
voltage of 2.0 kV and the sampling and extraction cone voltages were 20 V and 4 V, 
respectively. The source temperature was 80 °C and the desolvation gas flow rate was 
400 L/hr at a temperature of 200 °C. The Triwave settings used were as follows: the 
trap and transfer collision energies were 6.0 V and 4.0 V, respectively, the IMS gas flow 
was 25 mL/min, the trap DC entrance, bias and exit were 5.0 V, 27.0 V and 5.0 V, 
respectively; IMS DC entrance and exit voltages were 5.0 V and 2.0 V, the transfer DC 
entrance and exit were both 2.0 V, and the IMS wave velocity and height were 350 m/s 
and 14 V, respectively. Spectra were acquired in positive ion mode over the range m/z 
1000-1300 and 35 acquisitions were summed to obtain a representative spectrum; all drift 
time results were expressed in ms. The instrument was calibrated using a CsI solution (1 
mg/mL) over the range m/z 500-2000.  
 
Results and Discussion 
HPLC separation of anthracyclines 
Propagation of Streptomyces olindensis ICB20 cultures that had originally produced 
CosD as the major anthracycline mutated over time to produce cultures that synthesised 
many different anthracycline molecules. Water-soluble material from methanol extracts 
of these mutant cultures were cleaned by extraction of less soluble anthracyclines into 
ethyl acetate, and the resulting compounds were separated by HPLC on a C4 column. 
Figure 2 shows the HPLC elution profile obtained. Fractions ranged in colour from 
yellow-brown through to red-purple. The elution profile of fractions of interest containing 
anthracycline molecules with two trisaccharide chains is expanded (inset). A positive ion 
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ESI mass spectrum of fraction A showed an ion of high abundance at m/z 594.8 
([CosD+2H]2+) and another at low abundance corresponding to the molecular ion, 
[CosD+1H]1+, at m/z 1189.6. The anthracyclines in other fractions had masses consistent 
with CosD minus one to three hydroxyl groups (-16 for each), with positive ions in the 
ESI mass spectra at m/z 1173.6 (fractions B, C, E, F, H), 1157.6 (fractions D, G, I, K) and 
1141.6 (fraction J).  
 
Exact masses of the anthracyclines 
The exact masses of the anthracycline in each of the fractions were determined in order to 
compare these with the calculated masses based on the proposed molecular formulae of 
the anthracyclines. Table 1 shows the proposed molecular formula for each fraction, its 
calculated mass, the experimental exact mass and the difference in ppm. In all cases the 
difference between the calculated and measured masses was within 3 ppm. Pure CosD 
subjected to elevated temperatures (e.g. 40 C) in the presence of water was subject to 
degradation, undergoing hydrolysis of the sugar residues. This process was catalysed 
under acid conditions (not shown). Since the masses of the anthracyclines purified in this 
work corresponded to molecules that contained two intact trisaccharide chains, this 
supports that the array of anthracyclines separated by HPLC were produced by the 
bacteria, rather than as a result of sample degradation. Some anthracyclines separated by 
C4 chromatography had the same mass, suggesting that the hydroxyl group(s) that had 
been "lost" from CosD (e.g. one hydroxyl group in the case of anthracyclines with mass 
1173.6) may have been lost in some cases from the sugars, or in other cases from the 
aglycone, accounting for their significantly different chromatographic behaviour.  
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Collisionally-activated dissociation of the anthracyclines 
There have been many dissociation studies of anthracyclines possessing a variety of sugar 
chains differing in their length, composition and position of attachment using precursor 
ions generated by an array of different techniques such as electron ionisation,13 chemical 
ionisation,14 field desorption,15 and fast atom bombardment.16 Furthermore, dissociation 
mechanisms have been proposed for CosD based on negative ion desorption chemical 
ionization17 and positive ion field desorption ionization tandem mass spectrometry.18 
Recently, the first positive ion electrospray ESI-MS/MS experiments have been carried 
out on doxorubicin, daunorubicin and the structurally similar epirubicin and idarubicin 
using a triple quadrupole mass spectrometer.19 In the current work, a linear quadrupole 
ion trap ESI mass spectrometer was used to distinguish among the anthracycline fractions 
separated by HPLC. In order to determine whether it was the aglycone and/or the sugars 
which were altered from the structure of CosD, each fraction was subjected to multiple 
stages of collisionally-activated dissociation (CAD). Figure 3 shows positive ESI-MS/MS 
(MS2) spectra obtained for CosD (A) and for the anthracyclines in fractions B (B) and C 
(C) from the HPLC. The precursor ions ([M+1H]1+) for CosD, fractions B and C were 
1189.4, 1173.2 and 1173.3, respectively. The product ions from CosD were: 1075.2 (low 
intensity, -114, consistent with the loss of one of the outermost sugars, 1 or 1 from 
Figure 1, Rho);  945.3 (high intensity, -130, consistent with the loss of a middle sugar, 2 
or  2, deFuc); 831.3 (low intensity, -114, consistent with the loss of the outermost sugar 
on the second trisaccharide chain, 1 or 1, Rho); 701.3 (high intensity, -130, consistent 
with the loss of the middle sugar from the second chain, 2 or 2, deFuc), and 544.3 (low 
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to moderate intensity, -157, consistent with loss of one of the innermost amino sugars,  3 
or 3, RhN).  The relative intensities of the product ions suggest that the glycosidic bond 
between sugars 2 and 3 (or 2 and 3) is more labile under the conditions than the bond 
between sugars 1 and 2 (or 1 and 2). Table 2 shows the product ions obtained in MSn 
experiments and gives the relative intensities of each ion in brackets. 
Collisional activation (MS3, 22 V) of the ion at 544.3 corresponding to the CosD 
aglycone with 1 RhN sugar remaining gave product ions at 369.0, 351.0 and 323.2. The 
former is consistent with an aglycone moiety that has lost the OH, most likely from C7, 
concomitant with dissociation of the last amino sugar from the aglycone. This could 
result in formation of a double bond between C7 and C8 of ring A, or may be the result of 
loss of the amino sugar followed by a rapid spontaneous loss of water. The ions at 351.0 
and 323.2 are consistent with loss of a second water molecule from the side chain of ring 
A followed by ethylene. Similar neutral losses (e.g. H2O, CO) from the side chain of ring 
A of doxorubicin, daunorubicin, epirubicin and idarubicin have previously been observed 
using a triple quadrupole ESI mass spectrometer19 as well as in the current work when 
daunorubicin and doxorubicin were subjected to CAD for comparison with CosD (not 
shown).  
Figures 3(B) and (C) show the MS2 spectra of the anthracyclines from fractions B 
and C which possess an identical molecular mass giving molecular ions at 1173.2 and 
1173.3, respectively. The fragmentation patterns/sequences of these compounds were 
markedly different confirming that they differ in structure. The differences could arise 
from a difference in either the sequence of the sugars in the trisaccharide chains or the 
number and positions of the oxygen group on the molecule (sugar or aglycone). Since 
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these anthracyclines have similar retention times when separated by HPLC (Figure 2), it 
is likely that they possess a general structure resembling CosD. Further, given that the 
main fragmentation pathway for CosD involves the cleavage of the glycosidic bonds 
where the 2-3 and 2-3 bonds are the most labile, and that charge is retained on the 
aglycone, the sequence of sugars in compounds B and C can be proposed. Collisionally-
activated dissociation of the precursor ion of compound B at 1173.2 gave 1059.1 (-114) 
 929.3 (-130)  815.4 (-114)  685.3 (-130)  528.3 (-157)  334.9 (MS3; -157 and 
-H2O). These dissociation products are consistent with compound B bearing the same 
sugar residues as CosD, but having a different aglycone. The aglycone of compound B 
gave a product on MS3 at 334.9 compared with 351.0 for CosD. This is consistent with 
the aglycone of compound B containing one fewer hydroxyl groups than CosD. 
Compound C dissociated via a similar fragmentation pathway suggesting loss of sugar 
residues, but in this case, the products are consistent with one of the middle sugars (2 or 
2, see Figure 1) having one less hydroxyl group. The product ions from 1173.3 for 
compound C were 1059.1 (-114)  945.1 (-114)  831.2 (-114)  701.2 (-130) 544.3 
(-157)  351.1 (MS3; -157 and -H2O). The final product at 351.1 suggests that the 
aglycone is the same as that for CosD. This however may not necessarily be true, since 
the aglycone may have the same mass, but may differ in the position of hydroxyl groups. 
In some cases (e.g. fractions C, E, F and H) molecules possessing the same dissociation 
sequence and the same product ions were well-separated by HPLC indicating that even if 
the sugar has the same molecular mass they might be somehow different (different 
position or stereochemistry of functional groups on the sugar, different conformation).  
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Table 2 summarises the results obtained for the CAD (MS2 and MS3) of all the 
anthracyclines present in the HPLC fractions (A to K). The table indicates the masses of 
all product ions observed in MS2 and their intensities, and the mass of the aglycone after 
loss of water and ethylene in some cases. It also shows the proposed number and position 
(sugar or aglycone) of hydroxyl groups that were "lost" compared to the structure of 
CosD. For all the fractions analysed this way, each of the major product ions 
(corresponding to the loss of one or more sugars) were selected for further CAD 
experiments (up to MS5) confirming the sequence of sugars observed in the MS2 and MS3 
experiments. These experiments were also carried out with the goal of determining 
whether the aglycone could be dissociated to gather supplementary information on the 
position its hydroxyl groups. No further fragmentation of the aglycone was observed 
beyond that described for CosD. The current MSn experiments have enabled some 
conclusions to be made about the sugars and aglycones present on these natural products 
using only small amount of material. Full structural determination will require NMR 
experiments, but at present these are not possible since these natural products were 
obtained in less than milligram quantities. 
 
Ion mobility ESI mass spectrometry of the anthracyclines 
Since structural isomers of the anthracyclines were separable by HPLC, experiments 
were carried out to determine whether these were also separable by ion mobility mass 
spectrometry (IMMS). The instrument used was a Waters Synapt HDMS which 
employs Triwave technology. In this mobility cell, a voltage pulse along rings of 
stacked electrodes generates a travelling voltage wave on which ions can "surf".20,21 Ions 
 14
with a greater collisional cross section will tend to fall behind the waves. Anthracyclines 
from the different HPLC fractions were analysed by IMMS separately, and after mixing 
aliquots from fractions containing anthracyclines with the same mass as judged by the 
exact mass measurements (Table 1). The drift times for the different anthracyclines are 
also shown in Table 1. Some of the fractions of the same mass had different drift times. 
For example, compounds B and H both have molecular ions at m/z 1173.6, but their drift 
times are 3.98 and 4.95 ms, respectively. Figures 4A and B show the drift and mobility 
plots that were obtained when fractions B and H were mixed together. The two 
anthracyclines are clearly resolvable. Figure 4C shows the ESI mass spectrum of the 
compound that gives rise to each peak in the mobility plot (B), confirming that they have 
the same elemental composition. Anthracyclines in fractions E and F were separable by 
HPLC (Figure 2) and had different drift times (4.43 and 3.92 ms, respectively), but had 
similar CAD mass spectra (Table 2). This is consistent with these two compounds 
bearing the same sequence of sugars, with differences arising possibly from different 
conformations of the sugars. In contrast, the compounds in fractions B and C were 
proposed to have different aglycones and a middle sugar differing by one hydroxyl group 
as judged by CAD mass spectra. These compounds were separable by HPLC, but not by 
ion mobility under the conditions of the current experiments. It is likely that the 
conformation of the sugars has a greater effect on mobility than the presence or absence 
of a hydroxyl group. It will be interesting to correlate the structures of these 
anthracyclines (once determined) with their drift times. This will be the subject of a more 
extensive investigation. 
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Conclusions 
Streptomyces sp. bacteria produce a vast array of natural products. Some of the 
anthracyclines that they produce are potent anticancer chemotherapeutics. In an effort to 
discover new anthracyclines with activities against different types of cancer, fewer side-
effects, and to counter the development of resistance of tumours to chemotherapy 
regimens, a range of strategies has been investigated. The most promising methods 
involve genetic manipulation of the bacteria.22 These methods have produced novel 
hydroxylated and glycosylated anthracyclines as a result of relaxed substrate specificity 
of the enzymes involved in anthracycline biosynthesis (e.g. oxygenases and 
glycosyltransferases).22 Previously we showed that Streptomyces olindensis ICB20 
produced CosD. Spontaneous mutations of this bacterium resulted in production of a 
range of anthracyclines with similar glycosylation patterns to CosD in that they contained 
two trisaccharide chains linked to the aglycone, but which varied in the numbers of 
hydroxyl groups on the aglycone and/or the sugars. Application of several mass 
spectrometric methods (using electrospray ionization) enabled preliminary 
characterisation of these anthracyclines. Exact mass determination confirmed the 
elemental composition of the compounds, and MSn experiments enabled insight into the 
positions from which hydroxyl groups had been ‘lost’ from the original CosD 
anthracycline. Since the two trisaccharide chains of CosD (and most of the related 
anthracyclines investigated here) are the same (or very similar), it was not possible to 
determine whether the first sugar residues that were dissociated in the CAD experiments 
were lost from the trisaccharide attached to C7 or C10 (Figure 1). Since travelling wave 
ion mobility mass spectrometry is relatively new, it was of interest to determine whether 
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some of the anthracyclines of the same mass could be separated in this mobility cell. The 
results were consistent with the proposal that the conformation of the sugars has a greater 
effect on mobility than the presence or absence of a hydroxyl group. A full understanding 
of the relationship among the structure of the anthracyclines and drift time in the 
travelling wave ion mobility mass spectrometer awaits full structural determination of 
these anthracyclines by NMR spectroscopy. These experiments will be challenging since 
the large number of anthracyclines produced meant that each was purified in only small 
quantities. The combination of mass spectrometric techniques used here enabled 
preliminary characterisation of the compounds using only very small amounts of 
material. 
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Figure 1: Structures of some anthracyclines. Daunorubicin (Dn, daunomycin), 
doxorubicin (Dx, adriamycin), aclarubicin (Acl) and cosmomycin D (CosD). The sugars 
on CosD are numbered: Sugar 1 and 1 is rhodinose (Rho); sugar 2 and 2 is 2-deoxy-L-
fucose (deFuc); sugar 3 and 3 is rhodosamine (RhN). The numbering system for 
aglycone ring system is shown in the top centre of the Figure. 
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Figure 2:  HPLC elution profile of water-soluble fractions from Streptomyces culture 
supernatants. The fractions eluting between 32 and 46 min are shown in detail (inset). 
The fractions are labeled A-K and fraction A is CosD. 
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Figure 3: ESI-MS/MS (MS2) of anthracycline fractions from HPLC. (A) CosD; (B) 
Fraction B; (C) Fraction C. The activation energies applied to give the spectra in A, B 
and C were 35, 36 and 38 V, respectively. The dotted lines were drawn to extend the 
intensities of the observed peaks so that the arrows indicating loss of fragments could be 
drawn. The numbers (1, 2, 3) on top of the arrows refer to the sugars (Figure 1) that are 
lost from the structures. Note that it is not possible to distinguish among sugar 1 and1, or 
2 and 2 or 3 and 3.   
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Figure 4: Waters Synapt HDMS ion mobility mass spectra of a mixture of fractions B 
and H. A. drift plot of a mixture of the two fractions. B.  Mobility of the two 
anthracyclines. The ion (1) with a drift time of 3.98 ms was confirmed as fraction B in 
experiments where each fraction was analysed separately, and ion (2) at 4.95 ms was 
from fraction H. C. ESI mass spectra of peaks at drift time 3.98 ms (1) and 4.95 ms (2). 
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Figure Legends 
Figure 1: Structures of some anthracyclines. Daunorubicin (Dn, daunomycin), 
doxorubicin (Dx, adriamycin), aclarubicin (Acl) and cosmomycin D (CosD). The sugars 
on CosD are numbered: Sugar 1 and 1 is rhodinose (Rho); sugar 2 and 2 is 2-deoxy-L-
fucose (deFuc); sugar 3 and 3 is rhodosamine (RhN). The numbering system for 
aglycone ring systems is shown in the top centre of the Figure. 
Figure 2:  HPLC elution profile of water-soluble fractions from Streptomyces culture 
supernatants. The fractions eluting between 32 and 46 min are shown in detail (inset). 
The fractions are labeled A-K and fraction A is CosD. 
Figure 3: ESI-MS/MS (MS2) of anthracycline fractions from HPLC. (A) CosD; (B) 
Fraction B; (C) Fraction C. The activation energies applied to give the spectra in A, B 
and C were 35, 36 and 38 V, respectively. The dotted lines were drawn to extend the 
intensities of the observed peaks so that the arrows indicating loss of fragments could be 
drawn. The numbers (1, 2, 3) on top of the arrows refer to the sugars (Figure 1) that are 
lost from the structures. Note that it is not possible to distinguish among sugar 1 and1, or 
2 and 2 or 3 and 3.   
Figure 4: Waters Synapt HDMS ion mobility mass spectra of a mixture of fractions B 
and H. A. drift plot of a mixture of the two fractions. B.  Mobility of the two 
anthracyclines. The ion (1) with a drift time of 3.98 ms was confirmed as fraction B in 
experiments where each fraction was analysed separately, and ion (2) at 4.95 ms was 
from fraction H. C. ESI mass spectra of peaks at drift time 3.98 ms (1) and 4.95 ms (2). 
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Table 1. Exact mass determination and drift times of the anthracyclines contained in the different 
fractions separated by HPLC. 
 
 
Fraction  
name 
Predicted formula 
Calculated  
mass (Da) 
Experimental  
mass (Da) 
Error (mDa) Error (ppm) Drift time (ms) 
A C60H89N2O22
+ 1189.5907 1189.5922 1.5 1.3 4.56 
B C60H89N2O21
+ 1173.5958 1173.5933 -2.5 -2.1 3.98 
C C60H89N2O21
+ 1173.5958 1173.5940 -1.8 -1.5 3.98 
D C60H89N2O20
+ 1157.6009 1157.5990 -1.9 -1.6 3.98 
E C60H89N2O21
+ 1173.5958 1173.9620 0.4 0.3 4.43 
F C60H89N2O21
+ 1173.5958 1173.5966 0.8 0.7 3.92 
G C60H89N2O20
+ 1157.6009 1157.5978 -3.1 -2.7 3.86 
H C60H89N2O21
+ 1173.5958 1173.5979 2.1 1.8 4.95 
I C60H89N2O20
+ 1157.6009 1157.6002 -0.7 -0.6 4.30 
J C60H89N2O19
+ 1141.6060 1141.6079 1.9 1.7 4.30 
K C60H89N2O20
+ 1157.6009 1157.5984 -2.5 -2.2 5.20 
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Table 2. Main product ions observed in the MS2 and MS3 spectra of the anthracyclines in fractions A to K with their relative abundances (RA %), and proposed assignment of the 
position(s) from which  –OH group(s) were ‘lost’ from CosD. 
 
      Compound      
 A B C D E F G H I J K 
Collision activation energy 
applied (MS2) 
35 V 36 V 38 V 39 V 37 V 36 V 36 V 37 V 36 V 37 V 38 V 
[M+H]+ 1189.4 (90) 1173.2 (59) 1173.1 (2) 1157.3 (39) 1173.3 (26) 1173.3 (36) 1157.2 (9) 1173.3 (38) 1157.2 (11) 1141.3 (62) 1157.1 (13) 
[M–114+H]+ 1075.2 (5) 1059.3 (5) 1059.1 (5) 1043.1 (6) 1059.2 (3) 1059.2 (5) 1043.3 (6) 1059.5 (2) 1043.2 (17) 1027.3 (3) 1043.5 (2) 
[M–2114+H]+ - 945.3 (2) 945.1 (48) 929.1 (61) 945.2 (78) 945.1 (98) 929.2 (100) 945.2 (100) 929.1 (7) 913.2 (94) 929.2 (86) 
[M–114–130+H]+ 945.3 (100) 929.3 (100) 929.1 (19) 913.1 (22) 929.2 (26) 929.1 (11) 913.2 (9) 929.2 (14) - - - 
[M–3114+H]+ - - 831.2 (5) 815.2 (10) 831.3 (3) 831.3 (4) 815.3 (4) 831.3 (3) 815.3 (6) 799.2 (6) 815.4 (4) 
[M–2114–130+H]+ 831.3 (7) 815.4 (8) 815.2 (4) 799.2 (7) 815.3 (3) 815.3 (4) 799.2 (3) 815.3 (3) - - - 
[M–4114+H]+ - - - - - - - - 701.3 (100) 685.3 (100) 701.2 (100) 
[M–3114–130+H]+ - - 701.2 (100) 685.2 (100) 701.3 (100) 701.3 (100) 685.3 (93) 701.3 (83) 685.4 (4) - - 
[M–2114–2130+H]+ 701.3 (83) 685.3 (80) 685.3 (8) - - - - - - - - 
[M–4114–157+H]+ a - - - - - - - - 544.3 (8) 528.2 (12) 544.2 (13) 
[M–3114–130–157+H]+ a - - 544.2 (11) 528.2 (14) 544.3 (19) 544.3 (10) 528.3 (10) 544.3 (13) - - - 
[M–2114–2130–157+H]+ a 544.3 (17) 528.3 (11) - - - - - - - - - 
Collision activation energy 
applied (MS3) 
22 V 24 V 22 V 24 V 22 V  23 V 23 V 24 V 24 V 23 V 21 V 
Aglycone – H2O 
b 369.0 (64) - 369.2 (7) - 369.1 (80) 369.1 (16) - 369.0 (100) 369.0 (6) - 369.1(45) 
Aglycone – 2 H2O 
b 351.0 (100) 334.9 (100) 351.1 (100) 335.0 (100) 351.1(100) 351.1 (100) 335.0 (100) 351.6 (38) 351.1 (100) 335.0 (100) 351.1 (33) 
Aglycone – 2 H2O – CH2=CH2 
b 323.2 (33) - 323.1 (15) 307.2 (12) 323.2 (10) 323.2 (22) - 323.1 c 323.2 (19) 307.4 c 323.2 (9) 
          
Position of the ‘missing’ oxygen     Number of ‘missing’ oxygens     
on sugar 2 or 2’d - - 1 1 1 1 1 1 2 2 2 
on the aglycone - 1 - 1 - - 1 - - 1 - 
 
am/z selected to obtain the aglycone fragment by MS3  
bobtained by MS3 of the fragment selected in a 
cobserved by MS4 experiments 
dsee Figure 1 
